| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jun 25, 2026 | Sale | $20.06 | 28,935 | 580,506 | 13,579 | Jun 25, 2026, 06:38 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jun 25, 2026 | Option/RSU Exercise | $8.05 | 28,935 | 232,847 | 42,514 | Jun 25, 2026, 06:38 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jun 02, 2026 | Option/RSU Exercise | $1.86 | 3,422 | 6,365 | 21,727 | Jun 02, 2026, 07:14 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jun 02, 2026 | Sale | $16.60 | 8,148 | 135,253 | 13,579 | Jun 02, 2026, 07:14 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | May 04, 2026 | Sale | $16.96 | 8,148 | 138,210 | 18,305 | May 04, 2026, 06:10 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | May 01, 2026 | Sale | $16.76 | 5,394 | 90,407 | 26,453 | May 01, 2026, 05:50 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Apr 30, 2026 | Option/RSU Exercise | - | 8,608 | - | 35,061 | Apr 30, 2026, 05:37 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Apr 30, 2026 | Sale | $16.65 | 3,214 | 53,498 | 31,847 | Apr 30, 2026, 05:37 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Apr 02, 2026 | Sale | $15.24 | 8,148 | 124,149 | 26,453 | Apr 02, 2026, 07:02 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Mar 02, 2026 | Sale | $15.44 | 8,148 | 125,793 | 34,601 | Mar 02, 2026, 07:05 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Feb 09, 2026 | Sale | $16.66 | 14,261 | 237,618 | 42,749 | Feb 09, 2026, 07:47 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jan 30, 2026 | Option/RSU Exercise | - | 10,534 | - | 61,431 | Jan 30, 2026, 08:38 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jan 30, 2026 | Sale | $16.60 | 4,421 | 73,381 | 57,098 | Jan 30, 2026, 08:38 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jan 20, 2026 | Option/RSU Exercise | $1.86 | 3,760 | 6,994 | 54,657 | Jan 20, 2026, 07:57 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jan 20, 2026 | Sale | $18.42 | 3,760 | 69,273 | 50,897 | Jan 20, 2026, 07:57 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Dec 18, 2025 | Sale | $17.90 | 3,760 | 67,314 | 51,097 | Dec 18, 2025, 06:08 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Dec 18, 2025 | Option/RSU Exercise | $1.86 | 3,760 | 6,994 | 54,657 | Dec 18, 2025, 06:08 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Nov 24, 2025 | Option/RSU Exercise | $1.86 | 37,600 | 69,936 | 88,497 | Nov 24, 2025, 06:06 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Nov 24, 2025 | Sale | $17.07 | 37,600 | 641,697 | 50,897 | Nov 24, 2025, 06:06 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Oct 30, 2025 | Option/RSU Exercise | - | 10,532 | - | 54,541 | Oct 30, 2025, 06:02 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Oct 30, 2025 | Sale | $12.80 | 3,644 | 46,631 | 50,897 | Oct 30, 2025, 06:02 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jul 30, 2025 | Option/RSU Exercise | - | 10,532 | - | 47,850 | Jul 30, 2025, 06:49 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jul 30, 2025 | Sale | $12.01 | 3,841 | 46,134 | 44,009 | Jul 30, 2025, 06:49 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Apr 30, 2025 | Option/RSU Exercise | - | 7,674 | - | 40,212 | Apr 30, 2025, 07:35 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Apr 30, 2025 | Sale | $11.50 | 2,894 | 33,286 | 37,318 | Apr 30, 2025, 07:35 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jan 31, 2025 | Option/RSU Exercise | $1.86 | 5,760 | 10,714 | 38,298 | Feb 03, 2025, 08:03 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jan 31, 2025 | Sale | $19.95 | 5,760 | 114,934 | 32,638 | Feb 03, 2025, 08:03 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jan 30, 2025 | Option/RSU Exercise | - | 7,674 | - | 35,758 | Jan 30, 2025, 07:53 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jan 30, 2025 | Sale | $19.85 | 3,220 | 63,929 | 32,829 | Jan 30, 2025, 07:53 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jan 02, 2025 | Option/RSU Exercise | $1.86 | 5,760 | 10,714 | 33,844 | Jan 02, 2025, 05:28 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jan 02, 2025 | Sale | $19.50 | 5,760 | 112,295 | 28,084 | Jan 02, 2025, 05:28 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Dec 02, 2024 | Sale | $21.73 | 5,760 | 125,155 | 28,084 | Dec 02, 2024, 06:00 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Dec 02, 2024 | Option/RSU Exercise | $1.86 | 5,760 | 10,714 | 33,844 | Dec 02, 2024, 06:00 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Nov 04, 2024 | Option/RSU Exercise | $9.57 | 3,290 | 31,485 | 31,374 | Nov 04, 2024, 05:48 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Nov 04, 2024 | Sale | $25.00 | 3,290 | 82,250 | 28,084 | Nov 04, 2024, 05:48 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Nov 01, 2024 | Option/RSU Exercise | $1.86 | 5,760 | 10,714 | 33,844 | Nov 01, 2024, 05:57 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Nov 01, 2024 | Sale | $24.28 | 5,760 | 139,867 | 28,084 | Nov 01, 2024, 05:57 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Oct 30, 2024 | Option/RSU Exercise | - | 7,674 | - | 32,266 | Oct 30, 2024, 08:30 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Oct 30, 2024 | Sale | $24.31 | 4,182 | 101,644 | 28,084 | Oct 30, 2024, 08:30 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Oct 14, 2024 | Option/RSU Exercise | $9.57 | 3,290 | 31,485 | 27,882 | Oct 15, 2024, 09:16 AM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Oct 14, 2024 | Sale | $25.00 | 3,290 | 82,250 | 24,592 | Oct 15, 2024, 09:16 AM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Oct 01, 2024 | Option/RSU Exercise | $1.86 | 5,760 | 10,714 | 30,352 | Oct 01, 2024, 07:36 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Oct 01, 2024 | Sale | $22.23 | 5,760 | 128,017 | 24,892 | Oct 01, 2024, 07:36 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Sep 03, 2024 | Option/RSU Exercise | $4.66 | 9,050 | 42,199 | 33,642 | Sep 03, 2024, 05:33 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Sep 03, 2024 | Sale | $24.94 | 9,050 | 225,736 | 24,792 | Sep 03, 2024, 05:33 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Aug 26, 2024 | Option/RSU Exercise | $6.08 | 9,870 | 60,046 | 34,462 | Aug 26, 2024, 06:23 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Aug 26, 2024 | Sale | $25.01 | 9,870 | 246,843 | 24,592 | Aug 26, 2024, 06:23 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Aug 01, 2024 | Sale | $21.43 | 5,760 | 123,459 | 24,892 | Aug 01, 2024, 07:06 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Aug 01, 2024 | Option/RSU Exercise | $1.86 | 5,760 | 10,714 | 30,352 | Aug 01, 2024, 07:06 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jul 30, 2024 | Option/RSU Exercise | - | 7,674 | - | 27,512 | Jul 30, 2024, 07:06 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jul 30, 2024 | Sale | $20.67 | 2,920 | 60,350 | 24,592 | Jul 30, 2024, 07:06 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jul 01, 2024 | Option/RSU Exercise | $1.86 | 5,760 | 10,714 | 25,598 | Jul 01, 2024, 06:35 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jul 01, 2024 | Sale | $20.81 | 5,760 | 119,837 | 20,639 | Jul 01, 2024, 06:35 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jun 13, 2024 | Option/RSU Exercise | $1.86 | 1,864 | 3,467 | 21,702 | Jun 13, 2024, 06:39 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jun 13, 2024 | Sale | $17.02 | 1,864 | 31,721 | 19,838 | Jun 13, 2024, 06:39 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jun 12, 2024 | Option/RSU Exercise | $1.86 | 1,900 | 3,534 | 21,738 | Jun 12, 2024, 07:30 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jun 12, 2024 | Sale | $17.01 | 1,900 | 32,319 | 19,838 | Jun 12, 2024, 07:30 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jun 05, 2024 | Sale | $17.00 | 400 | 6,801 | 19,838 | Jun 05, 2024, 06:01 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jun 05, 2024 | Option/RSU Exercise | $1.86 | 400 | 744 | 20,238 | Jun 05, 2024, 06:01 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jun 03, 2024 | Option/RSU Exercise | $1.86 | 1,596 | 2,969 | 21,434 | Jun 03, 2024, 06:36 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Apr 30, 2024 | Option/RSU Exercise | - | 3,924 | - | 21,351 | Apr 30, 2024, 06:33 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Apr 30, 2024 | Sale | $12.04 | 1,513 | 18,220 | 19,838 | Apr 30, 2024, 06:33 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jan 30, 2024 | Sale | $7.99 | 1,760 | 14,063 | 17,427 | Jan 30, 2024, 06:52 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Jan 30, 2024 | Option/RSU Exercise | - | 3,924 | - | 19,187 | Jan 30, 2024, 06:52 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Oct 30, 2023 | Option/RSU Exercise | - | 3,924 | - | 16,495 | Nov 01, 2023, 04:40 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | Chief Legal Officer | Oct 31, 2023 | Sale | $5.20 | 1,232 | 6,403 | 15,263 | Nov 01, 2023, 04:40 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Jul 30, 2023 | Option/RSU Exercise | - | 3,924 | - | 13,964 | Aug 01, 2023, 04:27 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Jul 31, 2023 | Sale | $9.65 | 1,420 | 13,710 | 12,544 | Aug 01, 2023, 04:27 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | May 01, 2023 | Sale | $9.88 | 682 | 6,736 | 10,040 | May 02, 2023, 04:32 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Apr 30, 2023 | Option/RSU Exercise | - | 1,924 | - | 10,722 | May 02, 2023, 04:32 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Jan 30, 2023 | Option/RSU Exercise | - | 1,924 | - | 8,109 | Feb 01, 2023, 04:16 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Jan 30, 2023 | Sale | $11.78 | 848 | 9,989 | 7,261 | Feb 01, 2023, 04:16 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Oct 30, 2022 | Option/RSU Exercise | - | 1,924 | - | 6,884 | Nov 01, 2022, 07:34 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Oct 31, 2022 | Sale | $12.88 | 699 | 9,003 | 6,185 | Nov 01, 2022, 07:34 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Jul 30, 2022 | Option/RSU Exercise | - | 1,924 | - | 5,327 | Aug 02, 2022, 05:50 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Aug 01, 2022 | Sale | $15.67 | 712 | 11,157 | 4,615 | Aug 02, 2022, 05:50 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Apr 30, 2022 | Option/RSU Exercise | - | 1,924 | - | 4,063 | May 03, 2022, 07:03 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | May 02, 2022 | Sale | $11.75 | 660 | 7,755 | 3,403 | May 03, 2022, 07:03 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Jan 10, 2022 | Sale | $27.14 | 1,200 | 32,568 | 1,286 | Jan 11, 2022, 04:10 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Jan 10, 2022 | Option/RSU Exercise | $1.86 | 1,200 | 2,232 | 2,486 | Jan 11, 2022, 04:10 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Dec 10, 2021 | Option/RSU Exercise | $1.86 | 1,200 | 2,232 | 2,486 | Dec 13, 2021, 04:47 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Dec 10, 2021 | Sale | $29.04 | 1,200 | 34,848 | 1,286 | Dec 13, 2021, 04:47 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Nov 10, 2021 | Option/RSU Exercise | $1.86 | 1,200 | 2,232 | 2,486 | Nov 12, 2021, 05:15 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Nov 10, 2021 | Sale | $32.38 | 1,200 | 38,856 | 1,286 | Nov 12, 2021, 05:15 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Oct 27, 2021 | Sale | $35.25 | 800 | 28,200 | 1,286 | Oct 28, 2021, 07:25 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Oct 27, 2021 | Option/RSU Exercise | $1.86 | 800 | 1,488 | 2,086 | Oct 28, 2021, 07:25 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Oct 11, 2021 | Option/RSU Exercise | $1.86 | 1,200 | 2,232 | 2,486 | Oct 12, 2021, 06:43 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Oct 11, 2021 | Sale | $27.36 | 1,200 | 32,832 | 1,286 | Oct 12, 2021, 06:43 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Sep 10, 2021 | Option/RSU Exercise | $1.86 | 2,000 | 3,720 | 3,286 | Sep 13, 2021, 04:07 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Sep 10, 2021 | Sale | $35.93 | 2,000 | 71,860 | 2,586 | Sep 13, 2021, 04:07 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Sep 07, 2021 | Option/RSU Exercise | $1.86 | 3,200 | 5,952 | 4,486 | Sep 08, 2021, 05:08 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Sep 07, 2021 | Sale | $35.25 | 3,200 | 112,800 | 1,286 | Sep 08, 2021, 05:08 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Aug 10, 2021 | Option/RSU Exercise | $1.86 | 1,200 | 2,232 | 2,005 | Aug 11, 2021, 06:21 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Aug 10, 2021 | Sale | $29.87 | 1,200 | 35,845 | 805 | Aug 11, 2021, 06:21 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Jul 20, 2021 | Sale | $27.00 | 1,200 | 32,400 | 805 | Jul 21, 2021, 05:34 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Jul 20, 2021 | Option/RSU Exercise | $1.86 | 1,200 | 2,232 | 2,005 | Jul 21, 2021, 05:34 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | May 10, 2021 | Option/RSU Exercise | $1.86 | 1,200 | 2,232 | 2,005 | May 11, 2021, 07:58 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | May 10, 2021 | Sale | $27.00 | 1,200 | 32,400 | 805 | May 11, 2021, 07:58 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Apr 28, 2021 | Option/RSU Exercise | $1.86 | 800 | 1,488 | 1,605 | Apr 29, 2021, 06:05 PM | |
| NRIX | Nurix Therapeutics, Inc. | Christine Ring | General Counsel | Apr 28, 2021 | Sale | $35.25 | 800 | 28,200 | 805 | Apr 29, 2021, 06:05 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More